ID
14481
Description
Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00895895
Link
https://clinicaltrials.gov/show/NCT00895895
Keywords
Versions (1)
- 4/17/16 4/17/16 -
Uploaded on
April 17, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Alzheimer Disease NCT00895895
Eligibility Alzheimer Disease NCT00895895
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
neurologic disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0027765
Description
depressive disorder; psychiatric disorder
Data type
boolean
Alias
- UMLS CUI [1]
- C0011581
- UMLS CUI [2]
- C0004936
Description
stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque
Data type
boolean
Alias
- UMLS CUI [1]
- C0038454
- UMLS CUI [2]
- C0007282
- UMLS CUI [3]
- C0149810
- UMLS CUI [4]
- C0332461
Description
memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors
Data type
boolean
Alias
- UMLS CUI [1]
- C0025242
- UMLS CUI [2]
- C0330206
- UMLS CUI [3]
- C0063033
- UMLS CUI [4]
- C0008425
Similar models
Eligibility Alzheimer Disease NCT00895895
- StudyEvent: Eligibility
C2828081 (UMLS CUI [2])
C0004936 (UMLS CUI [2])
C0007282 (UMLS CUI [2])
C0149810 (UMLS CUI [3])
C0332461 (UMLS CUI [4])
C0330206 (UMLS CUI [2])
C0063033 (UMLS CUI [3])
C0008425 (UMLS CUI [4])